PEDIATRICS Vol. 29 No. 1 January 1962, pp. 3-17
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cleveland, W. W.
Right arrow Articles by Wilkins, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cleveland, W. W.
Right arrow Articles by Wilkins, L.

DEATHS IN CONGENITAL ADRENAL HYPERPLASIA

William W. Cleveland M.D.1, Orville C. Green M.D.1, and Lawson Wilkins M.D.1

1 Department of Pediatrics, Johns Hopkins University, and The Johns Hopkins, Hospital

Since the advent of cortisone for treatment of congenital adrenal hyperplasia, eight patients have died, representing a mortality of approximately 8%. These cases are presented, with an analysis of the findings in an attempt to explain the cause of death. In three of these cases errors in management were considered as factors in the terminal illness. One child died of an unrelated disorder. The remaining four died under circumstances that allow no ready explanation for their death. The possible mechanisms in these patients are discussed, including a poorly understood relationship of disturbance in the central nervous system to disorders of adrenal metabolism.